We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Audit on bedside chemical pleurodesis in a palliative care setting: Brunei experience.
- Authors
Shaharudin, Muhammad Yusuf
- Abstract
Background: Malignant pleural effusion typically is a sign of aggressive and advanced disease with generally short life expectancy. This causes a lot of burdens symptomatically to patients with advanced malignancy. Hence, a lot of patients are made known early to palliative service to help optimise patients' symptomology. One of the procedures to help prevent the recurrence of symptomatic malignant pleural effusion is bedside chemical pleurodesis following thoracocentesis. This audit aims to assess the efficacy and safety of doing the above procedure in a palliative setting. Patients and methods: Retrospective electronic records of patients were reviewed from January 2020 until March 2022. Malignant pleural effusion was confirmed by cytological assessment of pleural fluid following chest tube drainage. Chemical pleurodesis was done by pleural fluid instillation of bleomycin, performed bedside by palliative physicians. Results: Twenty patients were identified out of which 7 were male and 13 were female. The mean age was 69.2 with 55% of them suffering from lung malignancy. Complete response is seen in 45% and partial response is seen in 20%. The failure rate is at 35%. The complications were minimal with only 5% of patients having fever and 10% having pleuritic pain. Conclusions: The audit shows bedside chemical pleurodesis performed by palliative physicians is as efficacious and safe compared to when it is done by other specialities. It helps improve symptoms in 65% of patients and thus improves the quality of life.
- Subjects
PLEURODESIS; PALLIATIVE treatment; LIFE expectancy; ELECTRONIC records; PHYSICIANS
- Publication
Palliative Medicine in Practice, 2023, Vol 17, Issue 2, p84
- ISSN
2545-0425
- Publication type
Article
- DOI
10.5603/PMPI.a2023.0004